InvestorsHub Logo
Followers 31
Posts 1641
Boards Moderated 0
Alias Born 03/09/2011

Re: ggwpq post# 404763

Thursday, 03/02/2023 9:23:45 PM

Thursday, March 02, 2023 9:23:45 PM

Post# of 429264
Agreed ggwpq. And the truth is that JT's strategy to tie up the inventory would have been a wise move if we had not had Du's ruling. As I've posted before, we wouldn't even be Amarin anymore.
When we lost the court ruling we had to scramble to stop the cash bleeding.
This is what KM inherited coming on board.
When Apotex came on board with their generic version, they cost cutted the generic price of V SUBSTANTIALLY. (This I know for a fact).
When they cut their price Hikma and Dr. Reddys followed suit and left us in a dire situation. We went back to the insurers and sold our product at substantially less price with promise of brand being sold for certain time commitments.
We then had to go back and work deals with the suppliers (rework the contracts paying penalties for not taking the inventory but losing a lot less than if we had kept our contractual agreements under the old contracts.
UK is coming along and so far US is stabilizing with slight loss still occurring.
If anyone expects us to make a profit this year it is extremely unlikely. As Tom said on the CC, we'll be losing cash for 2023.
2024 we should start becoming profitable with increased profits each quarter and the markets grow.
KM can adjust as the new board directs. He's got a ton of experience in Europe and is a very talented and capable individual. He needs to stay IMO even though it isn't the popular opinion on this MB.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News